Articles
Predicting the future of cancer immunotherapy: Using autoantibody biomarkers...
For a number of years now, immunotherapy has been seen as the dawn of a new era, and is the most promising approach to cancer...
Drug Research
KemPharm Enhances Pipeline with the Addition of KP879, a...
KemPharm, Inc. , a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced the addition of a new product candidate, KP879,...
Drug Research
PANTHERx Specialty Pharmacy and RxCrossroads by McKesson Collaborate to...
PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroads by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative...
Drug Research
Medigene AG: Medigene Signs Exclusive License Agreement with Leiden...
Medigene AG announced that it has entered into an exclusive license agreement with Leiden University Medical Center, the Netherlands, for worldwide rights to develop, manufacture,...
Drug Research
RetiPharma Secures Funding to Develop Treatments of Degenerative Eye...
RetiPharma, focusing on the development of products for the treatment of degenerative eye disorders based on an in vivo platform for translation from in vivo...
Drug Research
Sygnature Discovery announces multi target drug discovery deal with...
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has announced a multi-target, integrated drug discovery collaboration with Sitryx Therapeutics, a biopharmaceutical...
Drug Research
Proprietary Nasal Delivery Formulation of Diazepam Developed by Particle...
Proprietary nasal delivery formulation of diazepam for the treatment of epilepsy developed by CDMO, Particle Sciences, a Lubrizol LifeSciences company, has been submitted as a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.